Plasma TK1 Activity Predicts Outcome of ER+ HER2− Metastatic Breast Cancer Treated With Palbociclib and Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Plasma Thymidine Kinase 1 Activity and Outcome of ER+ HER2- Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
Breast Cancer Res 2020 Sep 14;22(1)98, L Cabel, D Rosenblum, F Lerebours, E Brain, D Loirat, M Bergqvist, P Cottu, A Donnadieu, A Bethune, N Kiavue, M Rodrigues, JY Pierga, ML Tanguy, FC BidardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.